Mounjaro®
Starting from £179.99/mo
Start journey Learn moreHeat affects Mounjaro in two distinct ways that matter to anyone on treatment: it can degrade the medicine if the pen gets too warm, and warm weather combined with the GI effects of tirzepatide raises your risk of dehydration. Both are manageable once you know what to watch for. Mounjaro (tirzepatide) is a prescription-only medicine, and questions about storage or how your body responds during hot weather are worth raising with your prescriber — but this page gives you the factual grounding first.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The decision most people face first is a practical one: you come home from a holiday, a summer barbecue or a long commute and realise your pen spent too long somewhere warm. Mounjaro's active ingredient, tirzepatide, is a protein-based molecule and proteins are sensitive to heat. Manufacturers and the medicine's patient information leaflet specify refrigerated storage between 2°C and 8°C for this reason. Once a pen has been taken out of the fridge it may be stored below 30°C for a limited period, but the exact window (including how long that period is and what temperatures count) is set out in the Mounjaro patient information leaflet, and that is the definitive source rather than anything written here.
What happens if a pen overheats? The tirzepatide may partially denature, meaning it loses its structure and therefore its effectiveness, or it may degrade in ways that are not visible to the eye. The liquid can look completely normal inside a compromised pen. That is why a pen left in a glove compartment on a 35°C July afternoon, or forgotten in a holiday bag in direct sunlight, should not simply be assumed to be fine. If you have any doubt, speak to your pharmacist before injecting. The NHS medicines page for tirzepatide echoes this guidance and is a practical first reference.
A good storage habit that many patients settle into: keep the current pen in the fridge door, where it is easy to access and away from the freezer compartment, freezing also ruins the medicine. If you are travelling, a small insulated wallet works better than hoping the hotel minibar stays reliably cool.
The second decision is about how you manage yourself in warm weather rather than how you manage your pen. Tirzepatide slows gastric emptying and reduces appetite, which most people welcome. But during hot weather, especially in the early weeks of treatment when nausea, loose stools or vomiting are more common, this creates a compounding dehydration risk. Heat causes fluid loss through sweating; GI symptoms cause further fluid loss; and a reduced sense of thirst (which some patients report on GLP-1 and dual GIP/GLP-1 agonist therapies) means your body may not prompt you to drink before you are already behind.
Dehydration on its own is unpleasant. In the context of GLP-1 medicines, the NHS England guidance on weight-management injections flags that severe dehydration from GI illness can affect kidney function, so the threshold for seeking medical help is lower than you might otherwise set it. If you want to understand more about how tirzepatide can affect kidney markers specifically, the page on Mounjaro and creatinine explains what the research shows about renal function during treatment. Signs to take seriously: very dark urine, dizziness when standing, marked reduction in urination, or confusion. These warrant prompt medical attention, not a wait-and-see approach.
The practical fix is deliberate hydration, not large volumes at once (which can worsen nausea) but small, regular sips of water or diluted drinks across the day. If you are curious about how other dietary factors intersect with treatment, the page on what to eat on Mounjaro covers protein targets and meal structure in more detail.
Heat does not mean you should avoid exercise during Mounjaro treatment. Quite the opposite, physical activity is part of the licensed indication, which pairs the medicine with a reduced-calorie diet and increased activity levels. But exercising in warm conditions does shift the calculation a little.
The main adjustment most people find necessary is timing. Morning or evening sessions, when air temperature is lower, sit more comfortably alongside the appetite suppression and any lingering nausea. High-intensity cardio in midday heat on an already-suppressed appetite is where some patients hit a wall, not because the medicine has failed, but because their fuel and fluid reserves were already low before they started. Some people also find that following a lower-carbohydrate approach affects how they feel during exercise, and if that applies to you, the page on keto and Mounjaro explores how that dietary pattern interacts with treatment. Strength and resistance training is particularly worth protecting on Mounjaro, since preserving muscle mass during caloric restriction is a common clinical priority; if you are thinking about how supplements like creatine fit alongside treatment, the creatine and Mounjaro page covers that evidence.
Protein adequacy matters more in warm weather too. Sweating increases some micronutrient losses and, combined with a smaller appetite, it becomes easier to fall short of intake that supports muscle. Aim for adequate protein at each meal, even if portions are smaller than before treatment. A question our prescribers hear regularly is whether the body enters a state of ketosis on Mounjaro, and the page on Mounjaro and ketosis addresses that in detail, including what the evidence says and when it might matter. A question our prescribers also hear regularly: whether coffee before a morning workout is fine on Mounjaro, that question has its own page if timing of stimulants is something you are managing.
Most people on Mounjaro navigate hot weather without incident. The situations that warrant a call are clear, and it is worth knowing them before summer rather than during it.
Contact your prescriber if: you are unsure whether a pen has been stored correctly and want guidance on whether to use it; you are experiencing persistent vomiting or diarrhoea in hot weather and cannot stay hydrated; or you want to adjust timing of your injection around a holiday. Seek urgent medical help for the symptoms of severe dehydration listed above, or for severe, persistent abdominal pain that radiates to the back, the MHRA's guidance on GLP-1 medicines identifies acute pancreatitis as a known, though infrequent, serious side effect requiring prompt assessment.
Report any suspected side effects at the MHRA Yellow Card scheme, it helps regulators monitor medicines in the real world. And if questions about your treatment come up that go beyond storage and heat, the nume FAQs page covers common queries, or you can reach the team directly through our contact page.
If you are not yet on treatment and are considering whether Mounjaro is right for you, a free consultation with our prescribers is the starting point, a real clinician reviews your details, not automated software, and suitability is assessed on the full clinical picture.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.